Abbott Laboratories international study of a verapamil SR-based treatment approach versus an atenolola£á¡§based strategy for patients with hypertension and coronary artery disease.
Abbott Laboratories international study of a verapamil SR-based treatment approach versus an atenolola£á¡§based strategy for patients with hypertension and coronary artery disease.